Seeking Novel Active Ingredients and Bio-Technologies Targeting New Mechanisms for Androgenetic Alopecia (AGA)

Must-Have Requirements

• Regulatory Framework: A clear regulatory pathway defined e.g cosmetic, MD, food supplement, medicine.
• Maturity: The proposed solution must be at a Technology Readiness Level (TRL) of > 5.
• Scientific Backing: Solutions must possess supporting scientific data (e.g., in vitro models) and a valid, scientifically supported mechanism of action (e.g., anti-inflammation, 5-alpha reductase inhibition, senescence, or new growth boosters).
• Geographical Scope: Solutions must be commercially viable within Spain and the European Union, while Latin America is also recognized as an area of interest.

Lacer is open to a range of collaborative business relationships, including:

• R&D contracts
• Licensing agreements
• Joint development partnerships(Open to companies, startups, and universities).

Technical requirements

• Advanced Technologies: The team is highly receptive to exploring advanced biological technologies, such as exosomes, provided they are relevant to the mechanisms in scope.
• Digital Innovations and Medical Device Engineering: Innovation in this space may involve digital tools, subscription models, or treatments that improve patient compliance through long-lasting effects.
• Intellectual Property: Patented technology is considered interesting and advantageous, but it is not a strict requirement for submission. Submissions must include comprehensive ingredient or technology details alongside supporting information.

Discarded solutions

• Established Ingredients: Non-differentiated or highly established ingredients on the market (e.g., Pea sprout extract).
• Rx topical minoxidil.

Possible solution areas

Dermatology | Biotechnology | Healthcare | Medical Device Engineering | Digital Innovations | Hair Care | Exosomes | Consumer Health | Active Ingredients​